Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Liver Neoplasms × Thalidomide × Clear all

Phase

Phase 2 4 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 4 Carcinoma, Hepatocellular 2 Neoplasms, Plasma Cell 1 NSCLC 1 Mouth Neoplasms 1 Liver Neoplasms 1 Leukemia, Large Granular Lymphocytic 1

Interventions

Sorafenib 3 lenvatinib 2 sintilimab 1 pembrolizumab 1 halofantrine 1 glucose-regulated proteins 1 camrelizumab 1 Tranexamic Acid 1 Thalidomide 1 Sunitinib 1 Standard of Care 1 Saline Solution 1 Oxaliplatin 1 Nadroparin 1 Lidocaine 1 Injections 1 Immune Checkpoint Inhibitors 1 Heparin, Low-Molecular-Weight 1 Gemcitabine 1 Folfox protocol 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00728078 2009-02-09

LDT-RFA

Sun Yat-sen University

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡